How Estrogen Influences SLE Across a Woman’s Lifespan – The Lupus Foundation of Australasia
The Lupus Foundation of Australasia shared a post on LinkedIn:
“Oestrogen and Lupus: Why It Matters
Systemic lupus erythematosus (SLE) is the most common form of lupus, and affects women at significantly higher rates. SLE affects many women, and changes in oestrogen levels can influence symptoms and flare-ups at different life stages.
From adolescence through to menopause, fluctuations in oestrogen can influence immune response, symptom severity, and flare risk.
Building awareness of these patterns is essential to improving patient education, supporting informed care, and strengthening outcomes for women living with lupus.
Click on the link below to learn more.
Disclaimer:
At THE LUPUS FOUNDATION OF AUSTRALASIA, our mission is to raise awareness and support patients with evidence-based information.
This content is intended for general informational purposes only and does not constitute medical advice. Individuals should consult a qualified healthcare professional before commencing any new exercise or treatment program, particularly those living with lupus.”
Alannah Hibbard, Medical Receptionist at Guardian Medical Pty Ltd, shared THE LUPUS FOUNDATION OF AUSTRALASIA’s post, adding:
“Excited to share that I have recently joined the Lupus Foundation of Australasia as a volunteer medical writer.
This May marked both World Lupus Day and Mother’s Day in Australia. It is an important reminder that lupus predominantly affects women and disease activity can change throughout puberty, pregnancy, and menopause. My first article explores this and unpacks how oestrogen influences lupus activity across the female lifespan.
Through this role I hope to contribute to patient education and advocacy, as well as raise awareness for a rare but debilitating disease. A huge thank you to the Lupus Foundation for this opportunity.”

Stay updated on all scientific advances in the field of fertility with Fertility News.
-
Oct 21, 2026, 17:57Ula Sankowska: What I’ll Bring to ASRM INNOVATE in Baltimore
-
Oct 21, 2026, 17:40Robert Borowczyk: The Invisible Waiting Room
-
Oct 21, 2026, 17:35Fereshteh Safian: Behind the Scenes of Reproductive Medicine
-
Oct 21, 2026, 17:20The Relationship Between Trophectoderm Biopsy and Early Pregnancy Outcomes – RBMO
-
Oct 21, 2026, 17:09Jules McDonald: The Future of Fertility Is Happening in Abu Dhabi
-
Oct 21, 2026, 16:53Ashley Evans: I Never Imagined I’d Be a Fertility Story with a Group of People Whom I Have Never Met…
-
Oct 21, 2026, 16:41Karthik Raj: Asherman’s Syndrome – When the Endometrium Cannot Regenerate Normally
-
Oct 21, 2026, 16:36Katy Encalade: A Few Misconceptions I Think Every Woman Considering Egg Donation Deserves to Understand
-
Oct 21, 2026, 16:21The FeRGI Working Group 2026-2027 – ESHRE SIG Reproductive Genetics
